Phenotypes Associated with This Genotype

Genotype
MGI:5546603

• Allelic Composition: Prmt5^{tm2c(EUCOMM)Wtsi}/Prmt5^{tm2c(EUCOMM)Wtsi}; Gt(ROSA)26Sor^{tm2(cre/ERT2)Brn}/Gt(ROSA)26Sor⁺
• Genetic Background: involves: 129P2/OlaHsd * 129S1/SvlmJ * C57BL/6Brd * C57BL/6N * SJL
• Cell Lines: EPD0160_2_A08

• ♀: phenotype observed in females
• ♂: phenotype observed in males
• N: normal phenotype

embryo

embryonic growth retardation ( J:201152 )

• at E15.5 following tamoxifen treatment at E10.5

decreased embryo size ( J:201152 )

• at E15.5 following tamoxifen treatment at E10.5

integument

pallor ( J:201152 )

• at E15.5 following tamoxifen treatment at E10.5

growth/size/body

embryonic growth retardation ( J:201152 )

• at E15.5 following tamoxifen treatment at E10.5

decreased embryo size ( J:201152 )

• at E15.5 following tamoxifen treatment at E10.5